Open Menu

Information for investors

News Release

Cambrex to Announce Fourth Quarter and Full Year 2017 Financial Results on February 8, 2018

EAST RUTHERFORD, N,J., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that fourth quarter and full year 2017 financial results will be released on Thursday, February 8, 2018 before the market opens.

The Company will host a conference call to discuss the financial results.

  Fourth Quarter 2017 Earnings Conference Call 
When: Thursday, February 8, 2018 at 8:30 a.m. Eastern Time
Dial-in: 1-888-394-8218 for U.S.
  1-323-701-0226 for International
  Passcode:  9709552
Dial-in Replay: 1-888-203-1112 for U.S.
  1-719-457-0820 for International
  Passcode:  9709552
  Available through Thursday, February 15, 2018

About Cambrex
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis and controlled substances.  For more information, please visit

Stephanie LaFiura                                                                              
Investor Relations Associate                                                             
Tel: 201-804-3037                                                      

Primary Logo

Cambrex Corporation